Cohen & Steers, Inc. (CNS) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CNS Revenue Growth
Revenue Breakdown (FY 2024)
CNS's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
CNS Revenue Analysis (2013–2024)
As of May 8, 2026, Cohen & Steers, Inc. (CNS) generated trailing twelve-month (TTM) revenue of $568.7 million, reflecting modest growth of +2.2% year-over-year. The most recent quarter (Q3 2025) recorded $141.7 million in revenue, down 0.5% sequentially.
Looking at the longer-term picture, CNS's 5-year compound annual growth rate (CAGR) stands at +4.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $583.8 million in 2021.
Revenue diversification analysis shows CNS's business is primarily driven by Open-End Investment Funds (56%), Institutional Accounts (25%), and Closed-End Investment Funds (19%). With over half of revenue concentrated in Open-End Investment Funds, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including VRTS, VCTR, and DHIL. Compare CNS vs VRTS →
CNS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CNSCurrent | $569M | +2.2% | +4.7% | 33.4% | |
 VRTS | $831M | - | - | 17.4% | |
 VCTR | $1.3B | - | - | 42.5% | |
 DHIL | $158M | - | - | 38.4% | |
 GROW | $8M | - | - | -35.3% | |
 HNNA | $36M | - | - | 37.0% |
CNS Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $517.4M | - | $242.3M | 46.8% | $172.9M | 33.4% |
| 2023 | $489.6M | - | $235.3M | 48.1% | $164.5M | 33.6% |
| 2022 | $573.7M | - | $282.0M | 49.1% | $215.9M | 37.6% |
| 2021 | $583.8M | - | $312.5M | 53.5% | $260.4M | 44.6% |
| 2020 | $430.9M | - | $159.4M | 37.0% | $95.1M | 22.1% |
| 2019 | $410.8M | - | $212.2M | 51.6% | $160.1M | 39.0% |
| 2018 | $391.5M | - | $210.2M | 53.7% | $147.0M | 37.6% |
| 2017 | $383.0M | - | $205.6M | 53.7% | $154.7M | 40.4% |
| 2016 | $353.6M | - | $184.9M | 52.3% | $135.5M | 38.3% |
| 2015 | $330.3M | - | $186.2M | 56.4% | $127.5M | 38.6% |
See CNS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CNS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CNS vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonCNS — Frequently Asked Questions
Quick answers to the most common questions about buying CNS stock.
Is CNS's revenue growth accelerating or slowing?
CNS revenue growth slowed to +2.2%, below the 5-year CAGR of +4.7%. TTM revenue is $569M. The deceleration marks a shift from historical growth rates.
What is CNS's long-term revenue growth rate?
Cohen & Steers, Inc.'s 5-year revenue CAGR of +4.7% reflects the variable expansion pattern. Current YoY growth of +2.2% is near this long-term average.
How is CNS's revenue distributed by segment?
CNS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.